Evidence map›Paper›PMID 34158506›Full record

ArticleNature communications2021

The Atr-Chek1 pathway inhibits axon regeneration in response to Piezo-dependent mechanosensation.

Feng Li, Tsz Y Lo, Leann Miles, Qin Wang, Harun N Noristani, Dan Li, Jingwen Niu, Shannon Trombley, Jessica I Goldshteyn, Chuxi Wang and 11 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 2 countries.

Feng Li *Raymond G. Perelman Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Tsz Y Lo *Raymond G. Perelman Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Leann Miles *The Graduate Group in Biochemistry and Molecular Biophysics, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0001-7554-4051
Qin Wang *Raymond G. Perelman Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0001-7447-1671
Harun N NoristaniShriners Hospitals Pediatric Research Center (Center for Neurorehabilitation and Neural Repair), Temple University School of Medicine, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0001-7742-140X
Dan LiRaymond G. Perelman Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Jingwen NiuShriners Hospitals Pediatric Research Center (Center for Neurorehabilitation and Neural Repair), Temple University School of Medicine, Philadelphia, PA, USA.
Shannon TrombleyRaymond G. Perelman Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Jessica I GoldshteynRaymond G. Perelman Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Chuxi WangRaymond G. Perelman Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Shuchao WangRaymond G. Perelman Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Jingyun QiuRaymond G. Perelman Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Katarzyna PogodaInstitute for Medicine and Engineering, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0001-6994-3435
Kalpana MandalInstitute for Medicine and Engineering, University of Pennsylvania, Philadelphia, PA, USA.
Megan BrewsterDepartment of Dermatology, University of Pennsylvania, Philadelphia, PA, USA.
Panteleimon RompolasDepartment of Dermatology, University of Pennsylvania, Philadelphia, PA, USA.
Ye HeThe City University of New York, Graduate Center - Advanced Science Research Center, Neuroscience Initiative, New York, NY, USA.
Paul A JanmeyInstitute for Medicine and Engineering, University of Pennsylvania, Philadelphia, PA, USA.
Gareth M ThomasShriners Hospitals Pediatric Research Center (Center for Neurorehabilitation and Neural Repair), Temple University School of Medicine, Philadelphia, PA, USA.
Shuxin LiShriners Hospitals Pediatric Research Center (Center for Neurorehabilitation and Neural Repair), Temple University School of Medicine, Philadelphia, PA, USA.
Yuanquan SongRaymond G. Perelman Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. songy2@email.chop.edu.ORCID http://orcid.org/0000-0001-7699-2059
Children's Hospital of Philadelphia · USUniversity of Pennsylvania · USTemple University · USInstitute of Nuclear Physics, Polish Academy of Sciences · PLThe Graduate Center, CUNY · US

Funding

Targeting Atr to promote regeneration and functional recovery after neural injuryR01NS107392 · NINDS · CHILDREN'S HOSP OF PHILADELPHIA · PI SONG, YUANQUAN · 2018 to 2022
$1.9M
Develop a combinatorial therapy for spinal cord injuryR01NS105961 · NINDS · TEMPLE UNIV OF THE COMMONWEALTH · PI LI, SHUXIN, ZOU, YIMIN · 2018 to 2022
$1.7M
Mechanistic studies of novel factors regulating axon regeneration in the PNS/CNSR00NS088211 · NINDS · CHILDREN'S HOSP OF PHILADELPHIA · PI SONG, YUANQUAN · 2016 to 2018
$728k
NINDS NIH HHS R00 NS088211NINDS NIH HHS R01 NS105961NINDS NIH HHS R01 NS107392
6 · The paper itself

Abstract

Atr is a serine/threonine kinase, known to sense single-stranded DNA breaks and activate the DNA damage checkpoint by phosphorylating Chek1, which inhibits Cdc25, causing cell cycle arrest. This pathway has not been implicated in neuroregeneration. We show that in Drosophila sensory neurons removing Atr or Chek1, or overexpressing Cdc25 promotes regeneration, whereas Atr or Chek1 overexpression, or Cdc25 knockdown impedes regeneration. Inhibiting the Atr-associated checkpoint complex in neurons promotes regeneration and improves synapse/behavioral recovery after CNS injury. Independent of DNA damage, Atr responds to the mechanical stimulus elicited during regeneration, via the mechanosensitive ion channel Piezo and its downstream NO signaling. Sensory neuron-specific knockout of Atr in adult mice, or pharmacological inhibition of Atr-Chek1 in mammalian neurons in vitro and in flies in vivo enhances regeneration. Our findings reveal the Piezo-Atr-Chek1-Cdc25 axis as an evolutionarily conserved inhibitory mechanism for regeneration, and identify potential therapeutic targets for treating nervous system trauma.

Indexed as

AnimalsAnimals, Genetically ModifiedAtaxia Telangiectasia Mutated ProteinsAxonsCell Cycle ProteinsCheckpoint Kinase 1Drosophila melanogasterDrosophila ProteinsHEK293 CellsHumansIon ChannelsMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicNerve RegenerationAtaxia Telangiectasia Mutated ProteinsAtr protein, mouseCell Cycle ProteinsCheckpoint Kinase 1Drosophila ProteinsIon ChannelsMei-41 protein, DrosophilaPiezo1 protein, mousePiezo protein, DrosophilaProtein Serine-Threonine Kinases

Identifiers

PMID34158506
PMCPMC8219705
OpenAlexW3175335784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.